Photocure ASA (PHCUF)

Market Cap	178.14M +38.1%
Revenue (ttm)	53.82M +2.2%
Net Income	212.05K -85.0%
EPS	0.01 -85.2%
Shares Out	n/a
PE Ratio	840.06
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,800
Average Volume	624
Open	7.00
Previous Close	7.00
Day's Range	7.00 - 7.00
52-Week Range	4.32 - 7.00
Beta	0.37
RSI	58.77
Earnings Date	Feb 18, 2026

About Photocure ASA

Photocure ASA, together with its subsidiaries, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products. It operates through Commercial Franchise and Development Portfolio segments. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus-induced cervical precancerous lesions. The company has a license agreement with Asieris MediTech Co to develop and commercialize Cevira; and a strategic agreemen...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 101
• Stock Exchange: OTCMKTS
• Ticker Symbol: PHCUF

Financial Performance

Financial numbers in NOK